Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Ganguly 2022 MitoFit"

From Bioblast
Line 1: Line 1:
{{Publication
{{Publication
|title=Ganguly U, Bir A, Chakrabarti S (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. 2022.13. https://doi.org/10.26124/mitofit: 2022-0013
|title=Ganguly U, Bir A, Chakrabarti S (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. 2022.13. https://doi.org/10.26124/mitofit:2022-0013
|info=[[File:MitoFit Preprints pdf.png|left|160px|link=https://wiki.oroboros.at/images/6/64/Ganguly_2022_MitoFit.pdf|MitoFit pdf]] [https://wiki.oroboros.at/images/6/64/Ganguly_2022_MitoFit.pdf Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways]<br/>
|info=[[File:MitoFit Preprints pdf.png|left|160px|link=https://wiki.oroboros.at/images/6/64/Ganguly_2022_MitoFit.pdf|MitoFit pdf]] [https://wiki.oroboros.at/images/6/64/Ganguly_2022_MitoFit.pdf Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways]<br/>
|authors=Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka
|authors=Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka

Revision as of 14:25, 19 April 2022

Publications in the MiPMap
Ganguly U, Bir A, Chakrabarti S (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. 2022.13. https://doi.org/10.26124/mitofit:2022-0013

Β»

MitoFit pdf

Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways

Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka (2022-04-19) MitoFit Prep

Abstract: Ferroptosis has been identified as a type of regulated cell death triggered by a diverse set of agents with implications in various diseases like cancer and neurodegenerative diseases. Ferroptosis is iron-dependent and accompanied by an accumulation of reactive oxygen species (ROS) and lipid oxidation products, a depletion of reduced glutathione, mitochondrial morphological alterations and the rupture of cell membrane; the process is inhibited by specific antioxidants like ferrostatin-1 and liproxstatin-1 and by other general antioxidants like the iron-chelator deferoxamine, vitamin E and N-acetylcysteine. However, the mechanism of cell death in ferroptosis subsequent to the accumulation of ROS and lipid oxidation products is not clearly established. We show here that the classical mitochondrial Complex I inhibitor rotenone (0.5 Β΅M) causes death of SH-SY5Y cells (a human neuroblastoma cell line) over a period of 48 h accompanied by mitochondrial membrane depolarization and intracellular ATP depletion. This is associated with an intracellular accumulation of ROS and the lipid oxidation product malondialdehyde or MDA and a decrease in reduced glutathione content. All these processes are inhibited very conspicuously by specific inhibitors of ferroptosis such as ferrostatin-1 and liproxstatin-1. However, the decrease in Complex I activity upon rotenone-treatment of SH-SY5Y cells is not significantly recovered by ferrostatin-1 and liproxstatin-1. When the rotenone-treated cells are analyzed morphologically by Hoechst 33258 and propidium iodide (PI) staining, a mixed picture is noticed with densely fluorescent and condensed nuclei indicating apoptotic death of cells (Hoechst 33258) and also significant numbers of necrotic cells with bright red nuclei (PI staining). β€’ Keywords: rotenone, mitochondria, ferroptosis, reactive oxygen species, neurodegeneration β€’ Bioblast editor: Tindle-Solomon L β€’ O2k-Network Lab: IN Haldia Chakrabarti S


Labels:






Bioblast 2022